Detect Disease Earlier

We are building AI-enabled healthcare solutions that improve patient outcomes and reduce the cost of patient care for Medicare Advantage plans

Follow Our Journey

Receive updates directly to your inbox

Our Opportunity

Cancer is the leading cause of death across the globe.

And, it’s growing:

2024 will be the first year that new cancer diagnoses exceed 2M in the U.S. 1

Annual global cancer diagnoses are expected to rise to 29.9M by 2040. 2

U.S. cancer expenditures were $208.9B in 2020 and are trending up as the U.S. population ages. 3

 

Our Mission

 

Together, We Can Lower Healthcare Costs and Improve Patient Outcomes:

Treating metastatic cancers can lead to 7 times higher costs than treating early-stage cancers. 4

Early diagnosis across 19 cancers could result in an estimated $26 billion cost-savings, representing about 17% of the direct costs related to cancer treatment. 5

Our Opportunity

Cancer is the leading cause of death across the globe. And, it’s growing:

2024 will be the first year that new cancer diagnoses exceed 2M in the U.S. 1

Annual global cancer diagnoses are expected to rise to 29.9M by 2040. 2

U.S. cancer expenditures were $208.9B in 2020 and are trending up as the U.S. population ages. 3

Our Mission

Together, We Can Lower Healthcare Costs and Improve Patient Outcomes.

Treating metastatic cancers can lead to 7 times higher costs than treating early-stage cancers. 4

Early diagnosis across 19 cancers could result in an estimated $26 billion cost-savings, representing about 17% of the direct costs related to cancer treatment. 5

 


Our Team

We are a Team of Entrepreneurs, AI Engineers, Marketers, Cancer Survivors, Doctors, and Researchers.

Tom Knight, AI Engineer

Tom Knight

Founder & CEO

AI Healthcare Entrepreneur

Branden Lisi

Chief Patient Advocate

Stage IV Cancer Survivor | Seasoned marketer and entrepreneur focused on improving patient outcomes while lowering the cost of care.

AJ Alix

Head of Product

Serial Entrepreneur | AI Engineer


Dr. Ravi B. Parikh

Research Team

Ravi B. Parikh, MD, MPP, FACP is a medical oncologist and directs the Human-Algorithm Collaboration Lab (HACLab) at Emory University and Winship Cancer Institute, which develops scalable interventions based on advanced predictive and diagnostic algorithms to improve clinical care and health policy.

Dr. Vincent Marconi

Research Team

Director of Infectious Diseases Research at the Atlanta VA Medical Center and a Professor of Medicine in the Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine and jointly a Professor of Global Health in the Rollins School of Public Health and the Emory Vaccine Center, Emory University.

Yan Sun, PhD

Research Team

Director of the Genetic and Molecular Epidemiology (GME) Certificate Program at Rollins School of Public Health.

Jeff Skolnick, PhD

Research Team

Regent’s Professor, Mary and Maisie Gibson Chair and GRA Eminent Scholar in Computational Systems Biology.

Sig Mosley

Board Member

Sig Mosley is the Managing Partner of Mosley Ventures, a venture fund investing in early stage technology startups in the Southeast and a Venture Partner in Zane Venture Fund. He is also an advisor to Silicon Road Ventures.

Widely regarded as “The Godfather of Angel Investing,” a title he earned as president of Imlay Investments, Inc.

Frank Wingate

Board Member

Co-founder and CEO of Industrial Computer Corporation, and more recently co-founder of LifeSpan Technologies.

Frank has a Masters Degree in electrical engineering from Stanford University.

Contact Us

Fill out the form below and we will be in touch.

Follow Our Journey

Receive updates directly to your inbox.